drugset / Trial / NCT03502395

Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion

NCT03502395

Phase 1 Completed 80 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

A prospective, double blinded and randomized study included women with breast cancer and underwent mastectomy, and randomly allocated into two groups of equal size. Lidocaine group and control group.

Timeline

Start
2017-04-04
Primary completion
2018-01-21
Completion
2018-02-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications